Primary Job Title Chief Scientific Officer Primary Organization AmbAgon Therapeutics
Location Berkeley, California, United States Regions San Francisco Bay Area, West Coast, Western US Gender Female
LinkedIn View on LinkedIn
Nancy Pryer is a Chief Scientific Officer at AmbAgon Therapeutics. She has contributed to the discovery and development of eight marketed drugs in oncology and rare diseases. She joined Ambagon from DayOne Biopharmaceuticals, where she was CSO. Prior to DayOne, Nancy was Chief Development Officer at Nurix Therapeutics, a leader in targeted protein
degradation.
Nancy earned her Ph.D. in Biology from the University of North Carolina, Chapel Hill, and completed post-doctoral work in the lab of Nobel prize winner Randy Schekman at the University of California, Berkeley.
